Member-only story

Deadly Drugging of Dementia: Exposing the Neuroleptic Malignant Syndrome

Jack London

·11.5k Followers· Follow

Published in Neuroleptic Malignant Syndrome: Deadly Drugging Of Dementia

5 min read · 2 weeks before

477 View Claps

38 Respond

Save

Listen

Dementia, a cruel and debilitating condition, affects millions of elderly individuals worldwide. While there is no known cure, various treatment options aim to alleviate symptoms and improve quality of life. However, one particular class of drugs, known as neuroleptics or antipsychotics, has come under intense scrutiny due to its potentially fatal side effect: Neuroleptic Malignant Syndrome (NMS).

Understanding Neuroleptic Malignant Syndrome

NMS is a rare but severe and potentially life-threatening condition that can develop in individuals taking neuroleptic medications. It is characterized by a constellation of symptoms, including:

Neuroleptic Malignant Syndrome: Deadly Drugging of Dementia

by Victoria Allen

4.6 out of 5

Language	:	English
File size	:	2475 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	295 pages
Lending	:	Enabled

High fever (over 103°F or 39.4°C)
Muscle rigidity
Mental status changes (confusion, agitation, delirium)
Rapid heart rate and blood pressure instability
Sweating
Kidney failure

The exact mechanism of NMS is still not fully understood, but it is believed to involve a disruption in the brain's dopamine pathways. Dopamine is a neurotransmitter that plays a crucial role in motor control, mood regulation, and cognitive function.

Risk Factors for NMS

While NMS can occur in individuals of any age who are taking neuroleptic medications, certain factors increase the risk, including:

Elderly age
Multiple neuroleptic medications
High-potency neuroleptics
Rapid dose increases
Underlying medical conditions (such as Parkinson's disease, seizures, or dehydration)

Deadly Consequences

NMS is a medical emergency that requires immediate intervention. Without prompt treatment, it can lead to organ failure, coma, and even death. The mortality rate for NMS ranges from 10% to 20%, with higher rates among elderly patients.

The Silent Epidemic

Tragically, NMS often goes unrecognized or misdiagnosed, leading to delayed treatment and increased mortality. This is particularly concerning in nursing homes and other long-term care facilities, where elderly residents may be prescribed neuroleptic medications without adequate monitoring or informed consent.

Protecting Our Loved Ones

As caregivers, family members, and advocates, we have a responsibility to protect our loved ones from the horrors of NMS. This involves:

Educating ourselves about NMS and its risk factors
Questioning the use of neuroleptic medications, especially for elderly patients
Insisting on informed consent before any medication is prescribed
Monitoring our loved ones closely for signs and symptoms of NMS
Seeking immediate medical attention if NMS is suspected

Alternatives to Neuroleptics

While neuroleptics may be appropriate in certain situations, there are safer and more effective alternatives for managing behavioral symptoms in dementia, including:

Non-pharmacological interventions (e.g., music therapy, validation therapy, reminiscence therapy)
Cholinesterase inhibitors (e.g., donepezil, rivastigmine)
Memantine
Lifestyle modifications (e.g., exercise, healthy diet, adequate sleep)

Neuroleptic Malignant Syndrome is a deadly and preventable tragedy that continues to harm elderly individuals with dementia. It is time to shed light on this hidden epidemic and demand better care for our vulnerable population. By educating ourselves, advocating for our loved ones, and promoting safer treatment options, we can protect our elderly from the deadly drugging of dementia.

For more information and resources, please visit: